K-pop

TXT's Solo Album Debuts at No. 16 on the U.S. Billboard 200

Features six tracks, including the title track “Ice Cream” Best-Selling Album Among Solo Korean Artists Released This Year

KIM HYUNSIK
2026-07-22 10:14:18
[Edaily Starin KIM HYUNSIK Reporter] Yeonjun, a member of the boy group Tomorrow X Together (TXT), has made it onto the Billboard 200, the main U.S. album chart, with his solo album.
(Photo courtesy of Big Hit Music)
According to his agency, Big Hit Music, on the 22nd, Yeonjun’s second mini-album, “NO LABELS: PART 02,” ranked 16th on the latest Billboard 200 chart (dated July 25). This marks the highest ranking achieved by a Korean solo artist’s album released this year.
Following his first solo album released last year, Yeonjun demonstrated his strength by placing his new solo work on the Billboard 200. “NO LABELS: PART 02” took the No. 1 spot on the World Albums chart and ranked No. 4 on the Top Album Sales chart.
The album’s title track, “Ice Cream,” reached No. 89 on the Global (Excluding the U.S.) chart. Meanwhile, Yeonjun ranked 17th on the Artist 100 chart, which ranks artists.
“No Labels: Part 02” is an album consisting of six tracks in total, including “Ice Cream.” Yeonjun also included “Baby Wassup?” and “Long Way Long Ride,” songs for which he contributed to the lyrics, on the album.
Following the release of his new album, Yeonjun took first place on KBS 2TV’s “Music Bank” and MBC’s “Show! Music Core” with “Ice Cream.” He is scheduled to appear on Mnet’s “M Countdown” on the 23rd.

Economy

Corporation

IT·Science

Economy

From Buildings to Operating Companies… Rental Housing Platforms Swallowed Whole

The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
2026-08-11 00:34:03

Corporation

SK hynix Responds to Rumors of Chongqing Plant Stake Sale: "Nothing Has Been Finalized"

SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
2026-08-10 18:53:57

IT·Science

Medy-Tox Inc. Reports 11% Increase in Second-Quarter Revenue… ‘NewViju’ Emerges as New Growth Engine

Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …
2026-08-10 17:02:01